EPHX2 and neoplasm: Stimulating the production of endogenous pro-resolving EpFAs via ω-3 PUFAs supplementation and/or pharmacologic sEH inhibition improves the anti-tumor efficacy of ICI in murine tumor models, thus offering a molecular basis for modifying nutrition to stimulate inflammation resolution.